Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'postprandial hyperglycemia' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. de Souza, CJ; Gagen, K; Chen, W; Dragonas, N
      Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus

      DIABETES OBESITY & METABOLISM
    2. Weyer, C; Maggs, DG; Young, AA; Kolterman, OG
      Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improvedmetabolic control

      CURRENT PHARMACEUTICAL DESIGN
    3. Roach, P; Strack, T; Arora, V; Zhao, Z
      Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    4. Nyholm, B; Brock, B; Orskov, L; Schmitz, O
      Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Jakobsen, P; Lundbeck, JM; Kristiansen, M; Breinholt, J; Demuth, H; Pawlas, J; Candela, MPT; Andersen, B; Westergaard, N; Lundgren, K; Asano, N
      Iminosugars: Potential inhibitors of liver glycogen phosphorylase

      BIOORGANIC & MEDICINAL CHEMISTRY
    6. Dostou, J; Gerich, J
      Pathogenesis of type 2 diabetes mellitus

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    7. Raptis, SA; Dimitriadis, GD
      Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    8. Annuzzi, G; Del Prato, S; Arcari, R; Damato, AB; Benzi, L; Bruttomesso, D; Calderini, MC; Coscelli, C; Fedele, D; Galluzzo, A; Giordano, M; Giorgino, R; Lapolla, A; Orsini, P; Pagano, G; Santoro, D; Riccardi, G
      Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type I diabetic patients: A multicenter randomized crossover trial

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    9. Beisswenger, PJ; Szwergold, BS; Yeo, KT
      Glycated proteins in diabetes

      CLINICS IN LABORATORY MEDICINE
    10. Bosquet, F; Heurtier, A; Chastang, N; Jacqueminet, S
      Insulin status and adjustment in type 2 diabetic patients' treatment.

      REVUE DE MEDECINE INTERNE
    11. Di Mauro, M; Papalia, G; Le Moli, R; Nativo, B; Nicoletti, F; Lunetta, M
      Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function

      DIABETES RESEARCH AND CLINICAL PRACTICE
    12. Miyamoto, Y; Yoneda, M; Morikawa, A; Itoh, H; Makino, I
      Gastric neuropeptides and gastric motor abnormality in streptozotocin-induced diabetic rats - Observation for four weeks after streptozotocin

      DIGESTIVE DISEASES AND SCIENCES
    13. Misawa, K; Ichikawa, K; Ojima, K; Hamano, S; Kitamura, T; Komatsu, H
      Effect of KAD-1229, a nonsulfonylurea hypoglycemic agent, on plasma glucose and insulin in streptozotocin-induced diabetic dogs

      PHARMACOLOGY
    14. Malkki, Y; Virtanen, E
      Gastrointestinal effects of oat bran and oat gum - A review

      LEBENSMITTEL-WISSENSCHAFT UND-TECHNOLOGIE-FOOD SCIENCE AND TECHNOLOGY
    15. Bourdon, I; Olson, B; Backus, R; Richter, BD; Davis, PA; Schneeman, BO
      Beans, as a source of dietary fiber, increase cholecystokinin and apolipoprotein B48 response to test meals in men

      JOURNAL OF NUTRITION
    16. Rosak, C
      Insulin analogues: Structure, properties and therapeutic indications. Partone: Short-action insulin analogues

      INTERNIST
    17. Vella, A; Shah, P; Basu, R; Basu, A; Camilleri, M; Schwenk, WF; Rizza, RA
      Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration

      DIABETOLOGIA
    18. Basu, A; Basu, R; Shah, P; Vella, A; Johnson, CM; Jensen, M; Nair, KS; Schwenk, WF; Rizza, RA
      Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding - Additional evidence for a defect in hepatic glucokinase activity

      DIABETES
    19. Bavenholm, PN; Pigon, J; Ostenson, CG; Efendic, S
      Insulin sensitivity of suppression of endogenous glucose production is thesingle most important determinant of glucose tolerance

      DIABETES
    20. Vella, A; Shah, P; Basu, R; Basu, A; Camilleri, M; Schwenk, FW; Holst, JJ; Rizza, RA
      Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes

      DIABETES
    21. Shiota, M; Postic, C; Fujimoto, Y; Jetton, TL; Dixon, K; Pan, DH; Grimsby, J; Grippo, JF; Magnuson, MA; Cherrington, AD
      Glucokinase gene locus transgenic mice are resistant to the development ofobesity-induced type 2 diabetes

      DIABETES
    22. Heinemann, L; Heise, T
      Clinical efficacy and pharmacodynamics of the insulin analogs lispro, aspart and glargin

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    23. Bastyr, EJ; Huang, Y; Brunelle, RL; Vignati, L; Cox, DJ; Kotsanos, JG
      Factors associated with nocturnal hypoglycaemia among patients with type 2diabetes new to insulin therapy: experience with insulin lispro

      DIABETES OBESITY & METABOLISM
    24. Slama, G
      Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    25. Davidson, JA
      Hypoglycaemia as a barrier to improved glycaemic control

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    26. Malone, JK; Yang, H; Woodworth, JR; Huang, J; Campaigne, BN; Halle, JP; Yale, JF; Grossman, LD
      Humalog (R) Mix25 (TM) offers better mealtime glycemic control in patientswith type 1 or type 2 diabetes

      DIABETES & METABOLISM
    27. Gin, H; Rigalleau, V
      Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes

      DIABETES & METABOLISM
    28. Howorka, K; Pumprla, J; Schlusche, C; Wagner-Nosiska, D; Schabmann, A; Bradley, C
      Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: Assessment of improvements in treatment satisfaction with a new insulin analogue

      QUALITY OF LIFE RESEARCH
    29. Gerich, JE
      Addressing the insulin secretion defect: A logical first-line approach

      METABOLISM-CLINICAL AND EXPERIMENTAL
    30. Ahren, B; Holst, JJ; Efendic, S
      Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    31. Basu, A; Basu, R; Shah, P; Vella, A; Johnson, CM; Nair, KS; Jensen, MD; Schwenk, WF; Rizza, RA
      Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism - Evidence for a defect in haptic glucokinase activity

      DIABETES
    32. Nielsen, MF; Nyholm, B; Caumo, A; Chandramouli, V; Schumann, WC; Cobelli, C; Landan, BR; Rizza, RA; Schmitz, O
      Prandial glucose effectiveness and pasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes

      DIABETES
    33. Nelson, RW; Robertson, J; Feldman, EC; Briggs, C
      Effect of the alpha-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    34. Donner, TW; Wilber, JF; Ostrowski, D
      D-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes

      DIABETES OBESITY & METABOLISM
    35. Fisher, M
      Insulin lispro for the treatment of type 2 diabetes

      HOSPITAL MEDICINE
    36. Glazer, NB; Zalani, S; Anderson, JH; Bastyr, ED
      Safety of insulin lispro: Pooled data from clinical trials

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    37. Heinemann, L
      Hypoglycemia and insulin analogues: Is there a reduction in the incidence?

      JOURNAL OF DIABETES AND ITS COMPLICATIONS
    38. Axelsen, M; Lenner, RA; Lonnroth, P; Smith, U
      Breakfast glycaemic response in patients with type 2 diabetes: Effects of bedtime dietary carbohydrates

      EUROPEAN JOURNAL OF CLINICAL NUTRITION
    39. Akram, J; De Verga, V
      Insulin lispro (Lys(B28), Pro(B29)) in the treatment of diabetes during the fasting month of Ramadan

      DIABETIC MEDICINE
    40. Orskov, L; Nyholm, B; Hove, KY; Gravholt, CH; Moller, N; Schmitz, O
      Effects of the amylin analogue pramlintide on hepatic glucagon responses and intermediary metabolism in Type 1 diabetic subjects

      DIABETIC MEDICINE
    41. Shah, P; Basu, A; Basu, R; Rizza, R
      Impact of lack of suppression of glucagon on glucose tolerance in humans

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    42. Brange, J; Volund, A
      Insulin analogs with improved pharmacokinetic profiles

      ADVANCED DRUG DELIVERY REVIEWS
    43. Renner, R; Pfutzner, A; Trautmann, M; Harzer, O; Sauter, K; Landgraf, R
      Use of insulin lispro in continuous subcutaneous insulin infusion treatment - Results of a multicenter trial

      DIABETES CARE
    44. Zinman, B; Ross, S; Campos, RV; Strack, T
      Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen - Double-blind randomized prospective trial

      DIABETES CARE
    45. Koivisto, VA; Tuominen, JA; Ebeling, P
      Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients

      DIABETES CARE
    46. Rassam, AG; Zeise, TM; Burge, MR; Schade, DS
      Optimal administration of lispro insulin in hyperglycemic type 1 diabetes

      DIABETES CARE
    47. Bastyr, EJ; Johnson, ME; Trautmann, ME; Anderson, JH; Vignati, L
      Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure

      CLINICAL THERAPEUTICS
    48. Kruger, DF; Gatcomb, PM; Owen, SK
      Clinical implications of amylin and amylin deficiency

      DIABETES EDUCATOR
    49. Thorburn, AW; Proietto, J
      Peripheral tissue glucose uptake is not reduced after an oral glucose loadin Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus

      METABOLISM-CLINICAL AND EXPERIMENTAL
    50. Lin, SS; Wang, SY; Chen, EC; Chien, YW
      Insulin lispro: In-vivo potency determination by intravenous administration in conscious rabbits

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    51. Kong, MF; King, P; Macdonald, IA; Blackshaw, PE; Horowitz, M; Perkins, AC; Armstrong, E; Buchanan, KD; Tattersall, RB
      Euglycaemic hyperinsulinaemia does not affect gastric emptying in Type I and Type II diabetes mellitus

      DIABETOLOGIA
    52. Bolli, GB; Di Marchi, RD; Park, GD; Pramming, S; Koivisto, VA
      Insulin analogues and their potential in the management of diabetes mellitus

      DIABETOLOGIA
    53. Uchida, R; Nasu, A; Tokutake, S; Kasai, K; Tobe, K; Yamaji, N
      Synthesis of new N-containing maltooligosaccharides, alpha-amylase inhibitors, and their biological activities

      CHEMICAL & PHARMACEUTICAL BULLETIN
    54. Hermans, MP; Nobels, FR; De Leeuw, I
      Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: Overview of pharmacological and clinical data

      ACTA CLINICA BELGICA
    55. Bex, M; Buysschaert, M; De Leeuw, I; De Schepper, J; Fery, F; Hermans, MP; Keymeulen, B; Lauvaux, JP; Letiexhe, M; Mathieu, C; Nobels, FR; Rottiers, R; Scheen, A; Schmitt, H; Van Crombrugge, P; Van Gaal, L
      Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies

      ACTA CLINICA BELGICA
    56. Nobels, FR; Hermans, MP; De Leeuw, I
      Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue: Guidelines for its practical use

      ACTA CLINICA BELGICA
    57. Paquot, N; Roulin, D; Schneiter, P; Ruiz, J; Lefebvre, P; Pahud, P; Tappy, L
      Effects of regular insulin or insulin Lispro on glucose metabolism after an oral glucose load in patients with Type 2 diabetes mellitus

      DIABETES & METABOLISM
    58. RABASALHORET R; CHIASSON JL
      POTENTIAL OF ALPHA-GLUCOSIDASE INHIBITORS IN ELDERLY PATIENTS WITH DIABETES-MELLITUS AND IMPAIRED GLUCOSE-TOLERANCE

      Drugs & aging
    59. LEE WL; ZINMAN B
      FROM INSULIN TO INSULIN ANALOGS - PROGRESS IN THE TREATMENT OF TYPE-1DIABETES

      Diabetes reviews
    60. LEBOVITZ HE
      ALPHA-GLUCOSIDASE INHIBITORS AS AGENTS IN THE TREATMENT OF DIABETES

      Diabetes reviews
    61. BURGE MR; RASSAM AG; SCHADE DS
      LISPRO INSULIN - BENEFITS AND LIMITATIONS

      Trends in endocrinology and metabolism
    62. SCHERBAUM WA
      THE ROLE OF AMYLIN IN THE PHYSIOLOGY OF GLYCEMIC CONTROL

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    63. McCormack, J; Bassett, K
      The evidence for insulin lispro

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    64. SEIFARTH C; BERGMANN J; HOLST JJ; RITZEL R; SCHMIEGEL W; NAUCK MA
      PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    65. CERIELLO A
      THE EMERGING ROLE OF POSTPRANDIAL HYPERGLYCEMIC SPIKES IN THE PATHOGENESIS OF DIABETIC COMPLICATIONS

      Diabetic medicine
    66. Howorka, K; Pumprla, J; Schlusche, C
      Algorithm adaptation under functional insulin treatment during transfer from regular to insulin lispro

      DIABETES NUTRITION & METABOLISM
    67. Jansson, PA; Ebeling, P; Smith, U; Conget, I; Coves, VJ; Gomis, R; Lalli, C; Del Sindaco, P; Bolli, GB; Koivisto, VA
      Improved glycemic control can be better maintained with insulin lispro than with human regular insulin

      DIABETES NUTRITION & METABOLISM
    68. KUCERA ML; GRAHAM JP
      INSULIN LISPRO, A NEW INSULIN ANALOG

      Pharmacotherapy
    69. RIGALLEAU V; BEYLOT M; PACHIAUDI C; GUILLOT C; DELERIS G; GIN H
      MECHANISMS OF GLUCOSE-INTOLERANCE DURING TRIGLYCERIDE INFUSION

      American journal of physiology: endocrinology and metabolism
    70. LIVESEY G; WILSON PDG; DAINTY JR; BROWN JC; FAULKS RM; ROE MA; NEWMAN TA; EAGLES J; MELLON FA; GREENWOOD RH
      SIMULTANEOUS TIME-VARYING SYSTEMIC APPEARANCE OF ORAL AND HEPATIC GLUCOSE IN ADULTS MONITORED WITH STABLE ISOTOPES

      American journal of physiology: endocrinology and metabolism
    71. HALLER H
      THE CLINICAL IMPORTANCE OF POSTPRANDIAL GLUCOSE

      Diabetes research and clinical practice
    72. KELLEY DE; BIDOT P; FREEDMAN Z; HAAG B; PODLECKI D; RENDELL M; SCHIMEL D; WEISS S; TAYLOR T; KROL A; MAGNER J
      EFFICACY AND SAFETY OF ACARBOSE IN INSULIN-TREATED PATIENTS WITH TYPE-2 DIABETES

      Diabetes care
    73. BRUNELLE RL; LLEWELYN J; ANDERSON JH; GALE EAM; KOIVISTO VA
      METAANALYSIS OF THE EFFECT OF INSULIN LISPRO ON SEVERE HYPOGLYCEMIA IN PATIENTS WITH TYPE-1 DIABETES

      Diabetes care
    74. SHIBA Y; YAMASAKI Y; KUBOTA M; MATSUHISA M; TOMITA T; NAKAHARA I; MORISHIMA T; KAWAMORI R; HORI M
      INCREASED HEPATIC GLUCOSE-PRODUCTION AND DECREASED HEPATIC GLUCOSE-UPTAKE AT THE PREDIABETIC PHASE IN THE OTSUKA-LONG-EVANS-TOKUSHIMA FATTYRAT MODEL

      Metabolism, clinical and experimental
    75. ORHO M; BOSSHARD NU; BUIST NRM; GITZELMANN R; AYNSLEYGREEN A; BLUMEL P; GANNON MC; NUTTALL FQ; GROOP LC
      MUTATIONS IN THE LIVER-GLYCOGEN SYNTHASE GENE IN CHILDREN WITH HYPOGLYCEMIA DUE TO GLYCOGEN-STORAGE-DISEASE TYPE-0

      The Journal of clinical investigation
    76. WISE SD; NIELSEN MF; CRYER PE; RIZZA RA
      OVERNIGHT NORMALIZATION OF GLUCOSE-CONCENTRATIONS IMPROVES HEPATIC BUT NOT EXTRAHEPATIC INSULIN ACTION IN SUBJECTS WITH TYPE-2 DIABETES-MELLITUS

      The Journal of clinical endocrinology and metabolism
    77. KONG MF; STUBBS TA; KING P; MACDONALD IA; LAMBOURNE JE; BLACKSHAW PE; PERKINS AC; TATTERSALL RB
      THE EFFECT OF SINGLE DOSES OF PRAMLINTIDE ON GASTRIC-EMPTYING OF 2 MEALS IN MEN WITH IDDM

      Diabetologia
    78. NIELSEN MF; BASU R; WISE S; CAUMO A; COBELLI C; RIZZA RA
      NORMAL GLUCOSE-INDUCED SUPPRESSION OF GLUCOSE-PRODUCTION BUT IMPAIREDSTIMULATION OF GLUCOSE DISPOSAL IN TYPE-2 DIABETES - EVIDENCE FOR A CONCENTRATION-DEPENDENT DEFECT IN UPTAKE

      Diabetes
    79. TOTH EL; LEE KC
      GUIDELINES FOR USING INSULIN LISPRO

      Canadian family physician
    80. LUNETTA M; DIMAURO M; LEMOLI R; NICOLETTI F
      EFFECT OF OCTREOTIDE ON GROWTH-HORMONE, IGF-I, IGFBP-3, GLUCAGON, CORTISOL AND EPINEPHRINE RESPONSE-10 INSULIN-INDUCED HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETIC-PATIENTS

      DIABETES & METABOLISM
    81. LEBOVITZ HE
      ALPHA-GLUCOSIDASE INHIBITORS

      Endocrinology and metabolism clinics of North America
    82. YOUNG A
      ROLE OF AMYLIN IN NUTRIENT INTAKE - ANIMAL STUDIES

      Diabetic medicine
    83. SCHMITZ O; NYHOLM B; ORSKOV L; GRAVHOLT C; MOLLER N
      EFFECTS OF AMYLIN AND THE AMYLIN AGONIST PRAMLINTIDE ON GLUCOSE-METABOLISM

      Diabetic medicine
    84. LUNETTA M; DIMAURO M; LEMOLI R
      LACK OF PHARMACOLOGICAL EFFECT OF SUBCUTANEOUS OCTREOTIDE IN AN INSULIN-DEPENDENT DIABETIC PATIENT - REVERSAL AFTER MIXING WITH APROTININ

      Journal of endocrinological investigation
    85. HSU BRS; FU SH; HUANG YY; HSU AW; CHUANG KL; HUANG HS
      MACROAGGREGATED ALBUMIN POTENTIATES THE HYPOGLYCEMIC EFFECT OF MICROENCAPSULATED ISLETS IN THE FED STATE OF STREPTOZOTOCIN-INDUCED DIABETICMICE

      Journal of microencapsulation
    86. LUNETTA M; DIMAURO M; LEMOLI R; NICOLETTI F
      EFFECTS OF OCTREOTIDE ON GLYCEMIC CONTROL, GLUCOSE DISPOSAL, HEPATIC GLUCOSE-PRODUCTION AND COUNTERREGULATORY HORMONES SECRETION IN TYPE-1 AND TYPE-2 INSULIN-TREATED DIABETIC-PATIENTS

      Diabetes research and clinical practice
    87. GERICH JE
      METABOLIC ABNORMALITIES IN IMPAIRED GLUCOSE-TOLERANCE

      Metabolism, clinical and experimental
    88. LUDVIK B; NOLAN JJ; ROBERTS A; BALOGA J; JOYCE M; BELL JM; OLEFSKY JM
      EVIDENCE FOR DECREASED SPLANCHNIC GLUCOSE-UPTAKE AFTER ORAL GLUCOSE-ADMINISTRATION IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      The Journal of clinical investigation
    89. UTRIAINEN T; NUUTILA P; TAKALA T; VICINI P; RUOTSALAINEN U; RONNEMAA T; TOLVANEN T; RAITAKARI M; HAAPARANTA M; KIRVELA O; COBELLI C; YKIJARVINEN H
      INTACT INSULIN STIMULATION OF SKELETAL-MUSCLE BLOOD-FLOW, ITS HETEROGENEITY AND REDISTRIBUTION, BUT NOT OF GLUCOSE-UPTAKE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      The Journal of clinical investigation
    90. KONG MF; KING P; MACDONALD IA; STUBBS TA; PERKINS AC; BLACKSHAW PE; MOYSES C; TATTERSALL RB
      INFUSION OF PRAMLINTIDE, A HUMAN AMYLIN ANALOG, DELAYS GASTRIC-EMPTYING IN MEN WITH IDDM

      Diabetologia
    91. NIELSEN MF; WISE S; DINNEEN SF; SCHWENK WF; BASU A; RIZZA RA
      ASSESSMENT OF HEPATIC SENSITIVITY TO GLUCAGON IN NIDDM - USE AS A TOOL TO ESTIMATE THE CONTRIBUTION OF THE INDIRECT PATHWAY TO NOCTURNAL GLYCOGEN-SYNTHESIS

      Diabetes
    92. STUMVOLL M
      GLUCOSE-HOMEOSTASIS - PHYSIOLOGY AND NON- INSULIN-DEPENDENT DIABETES

      Deutsche Medizinische Wochenschrift
    93. MARTIN AE; MONTGOMERY PA
      ACARBOSE - AN ALPHA-GLUCOSIDASE INHIBITOR

      American journal of health-system pharmacy
    94. HOTTA K; KUWAJIMA M; ONO A; NAKAJIMA H; SHINGU R; MIYAGAWA J; NAMBA M; HANAFUSA T; NOGUCHI T; KONO N; MATSUZAWA Y
      DISORDERED EXPRESSION OF HEPATIC GLYCOLYTIC AND GLUCONEOGENIC ENZYMESIN OTSUKA LONG-EVANS TOKUSHIMA FATTY RATS WITH SPONTANEOUS LONG-TERM HYPERGLYCEMIA

      Biochimica et biophysica acta (G). General subjects
    95. LUNETTA M; DIMAURO M; LEMOLI R; NICOLETTI F
      EFFECT OF OCTREOTIDE ON BLOOD-GLUCOSE AND COUNTERREGULATORY HORMONES IN INSULIN-DEPENDENT DIABETIC-PATIENTS - THE ROLE OF DOSE AND ROUTE OFADMINISTRATION

      European Journal of Clinical Pharmacology
    96. RODEN M; PERSEGHIN G; PETERSEN KF; HWANG JH; CLINE GW; GEROW K; ROTHMAN DL; SHULMAN GI
      THE ROLES OF INSULIN AND GLUCAGON IN THE REGULATION OF HEPATIC GLYCOGEN-SYNTHESIS AND TURNOVER IN HUMANS

      The Journal of clinical investigation
    97. BASU A; ALZAID A; DINNEEN S; CAUMO A; COBELLI C; RIZZA RA
      EFFECTS OF A CHANGE IN THE PATTERN OF INSULIN DELIVERY ON CARBOHYDRATE-TOLERANCE IN DIABETIC AND NONDIABETIC HUMANS IN THE PRESENCE OF DIFFERING DEGREES OF INSULIN-RESISTANCE

      The Journal of clinical investigation
    98. KOJIMA M; TACHIKAKE N; KYOTANI Y; KONNO K; MARUO S; YAMAMOTO M; EZURE Y
      EFFECT OF DISSOLVED-OXYGEN AND PH ON MORANOLINE (1-DEOXYNOJIRIMYCIN) FERMENTATION BY STREPTOMYCES-LAVENDULAE

      Journal of fermentation and bioengineering
    99. ROGNSTAD R
      USE OF TRITIATED-WATER IN-VIVO TO ESTIMATE PATHWAYS OF LIVER-GLYCOGENSYNTHESIS

      Biochemical archives
    100. THORBURN A; LITCHFIELD A; FABRIS S; PROIETTO J
      ABNORMAL TRANSIENT RISE IN HEPATIC GLUCOSE-PRODUCTION AFTER ORAL GLUCOSE IN NON-INSULIN-DEPENDENT DIABETIC SUBJECTS

      Diabetes research and clinical practice


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 03:07:56